https://buyandbillbrief.com 2026-10-29T18:11:38.220Z daily 1 https://buyandbillbrief.com/sections/platform-mso-finance 2026-10-29T18:11:38.220Z weekly 0.5 https://buyandbillbrief.com/sections/340b-program 2026-10-18T18:50:52.055Z weekly 0.5 https://buyandbillbrief.com/sections/biologic-benchmarks 2026-10-08T19:50:25.546Z weekly 0.5 https://buyandbillbrief.com/sections/drug-cost-reimbursement 2026-09-23T23:18:07.162Z weekly 0.5 https://buyandbillbrief.com/sections/site-of-care-finance 2026-10-22T19:41:27.883Z weekly 0.5 https://buyandbillbrief.com/authors/darius-okonkwo 2026-10-29T18:11:38.220Z weekly 0.4 https://buyandbillbrief.com/authors/mei-lin-tsou 2026-10-29T18:11:38.220Z weekly 0.4 https://buyandbillbrief.com/authors/renata-szymborska 2026-10-29T18:11:38.220Z weekly 0.4 https://buyandbillbrief.com/authors/jerome-castellano 2026-10-29T18:11:38.220Z weekly 0.4 https://buyandbillbrief.com/posts/structural-levers-that-drive-infusion-reimbursement-improvement-across-a-multi-s https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/bd632ea0-d72b-494f-b07a-772a937809c5/canvas/04650c8f-3633-4a80-aef4-41aa3d3b8a39/generated/33247474-b2df-49f3-a87e-29078a56cbf5.png 2026-10-29T18:11:38.220Z monthly 0.7 https://buyandbillbrief.com/posts/scorecard-for-evaluating-operator-embedded-rcm-models-in-multi-site-infusion-pla https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/bd632ea0-d72b-494f-b07a-772a937809c5/canvas/04650c8f-3633-4a80-aef4-41aa3d3b8a39/generated/3348ccf0-d224-4b00-b6be-7f8012afba46.png 2026-10-28T20:02:09.359Z monthly 0.7 https://buyandbillbrief.com/posts/the-purpose-built-infusion-rcm-platform-as-a-platform-acquisition-prerequisite https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/bd632ea0-d72b-494f-b07a-772a937809c5/canvas/04650c8f-3633-4a80-aef4-41aa3d3b8a39/generated/5ee6f30b-490b-4e92-9e84-2d5f9410a206.png 2026-10-27T18:32:00.848Z monthly 0.7 https://buyandbillbrief.com/posts/vendor-selection-criteria-for-infusion-rcm-that-integrates-purpose-built-softwar https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/bd632ea0-d72b-494f-b07a-772a937809c5/canvas/04650c8f-3633-4a80-aef4-41aa3d3b8a39/generated/dd0481c1-086e-42c1-bc49-a1c423d92b58.png 2026-10-26T18:31:38.914Z monthly 0.7 https://buyandbillbrief.com/posts/why-general-purpose-rcm-platforms-underperform-on-infusion-billing-at-the-platfo https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/bd632ea0-d72b-494f-b07a-772a937809c5/canvas/04650c8f-3633-4a80-aef4-41aa3d3b8a39/generated/49a8c7de-da77-4582-b7d5-7eaad39ee254.png 2026-10-25T19:16:11.300Z monthly 0.7 https://buyandbillbrief.com/posts/payer-site-of-care-redirection-programs-and-revenue-impact https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/bd632ea0-d72b-494f-b07a-772a937809c5/canvas/04650c8f-3633-4a80-aef4-41aa3d3b8a39/generated/249fdbf0-39ed-455d-9650-a20f6a4c1069.png 2026-10-22T19:41:27.883Z monthly 0.7 https://buyandbillbrief.com/posts/hopd-vs-freestanding-infusion-center-reimbursement-comparison https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/bd632ea0-d72b-494f-b07a-772a937809c5/canvas/04650c8f-3633-4a80-aef4-41aa3d3b8a39/generated/a847b239-9802-4bf2-96f4-38170f7d2dc6.png 2026-10-21T19:37:25.097Z monthly 0.7 https://buyandbillbrief.com/posts/freestanding-infusion-center-chair-economics-and-revenue-per-visit https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/bd632ea0-d72b-494f-b07a-772a937809c5/canvas/04650c8f-3633-4a80-aef4-41aa3d3b8a39/generated/3f6dd2f8-bc4f-4fb1-b33b-afa86897fe91.png 2026-10-20T19:21:42.228Z monthly 0.7 https://buyandbillbrief.com/posts/340b-and-site-of-care-financial-interaction-in-mixed-setting-platforms https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/bd632ea0-d72b-494f-b07a-772a937809c5/canvas/04650c8f-3633-4a80-aef4-41aa3d3b8a39/generated/d4cb86cb-dcbd-4bae-b1f2-14b48936b403.png 2026-10-19T18:16:56.331Z monthly 0.7 https://buyandbillbrief.com/posts/340b-contract-pharmacy-rules-and-infusion-center-compliance https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/bd632ea0-d72b-494f-b07a-772a937809c5/canvas/04650c8f-3633-4a80-aef4-41aa3d3b8a39/generated/a8a87cf9-7769-4d56-a78d-fa47f909cb9d.png 2026-10-18T18:50:52.055Z monthly 0.7 https://buyandbillbrief.com/posts/state-level-340b-payer-access-laws-and-infusion-reimbursement https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/bd632ea0-d72b-494f-b07a-772a937809c5/canvas/04650c8f-3633-4a80-aef4-41aa3d3b8a39/generated/89d7f7b9-4d61-4cce-ad1b-fbb60b3089cc.png 2026-10-16T20:26:13.061Z monthly 0.7 https://buyandbillbrief.com/posts/hrsa-audit-risk-and-340b-compliance-documentation-for-infusion-groups https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/bd632ea0-d72b-494f-b07a-772a937809c5/canvas/04650c8f-3633-4a80-aef4-41aa3d3b8a39/generated/105c3e58-4a34-4531-8c11-78c13452e345.png 2026-10-14T18:52:34.969Z monthly 0.7 https://buyandbillbrief.com/posts/commercial-payer-340b-reimbursement-policy-changes https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/bd632ea0-d72b-494f-b07a-772a937809c5/canvas/04650c8f-3633-4a80-aef4-41aa3d3b8a39/generated/7c244e2a-c48c-433a-8751-5989ae8a08b4.png 2026-10-13T19:51:56.778Z monthly 0.7 https://buyandbillbrief.com/posts/340b-drug-acquisition-cost-vs-buy-and-bill-spread-economics https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/bd632ea0-d72b-494f-b07a-772a937809c5/canvas/04650c8f-3633-4a80-aef4-41aa3d3b8a39/generated/d047f104-ea33-4302-a68e-fccc7db150a4.png 2026-10-12T19:36:08.612Z monthly 0.7 https://buyandbillbrief.com/posts/340b-eligibility-requirements-for-infusion-centers https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/bd632ea0-d72b-494f-b07a-772a937809c5/canvas/04650c8f-3633-4a80-aef4-41aa3d3b8a39/generated/887604c9-e5ef-4562-976a-3cbcea024b74.png 2026-10-11T19:51:08.520Z monthly 0.7 https://buyandbillbrief.com/posts/340b-participation-strategy-for-pe-backed-infusion-platforms https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/bd632ea0-d72b-494f-b07a-772a937809c5/canvas/04650c8f-3633-4a80-aef4-41aa3d3b8a39/generated/f9e8f971-860f-4267-b1a5-82eeb52ea31c.png 2026-10-10T19:21:29.675Z monthly 0.7 https://buyandbillbrief.com/posts/340b-duplicate-discount-prevention-in-infusion-billing https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/bd632ea0-d72b-494f-b07a-772a937809c5/canvas/04650c8f-3633-4a80-aef4-41aa3d3b8a39/generated/502c2708-91d3-4d14-aff8-40552790de94.png 2026-10-09T18:10:38.212Z monthly 0.7 https://buyandbillbrief.com/posts/infliximab-biosimilar-reimbursement-benchmark-analysis https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/bd632ea0-d72b-494f-b07a-772a937809c5/canvas/04650c8f-3633-4a80-aef4-41aa3d3b8a39/generated/3494cea1-c161-492c-a23f-66185b896c22.png 2026-10-08T19:50:25.546Z monthly 0.7 https://buyandbillbrief.com/posts/biosimilar-reimbursement-rates-vs-reference-biologic-spread https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/bd632ea0-d72b-494f-b07a-772a937809c5/canvas/04650c8f-3633-4a80-aef4-41aa3d3b8a39/generated/eb77660e-fa4f-48c3-9255-a3e1e47b4955.png 2026-10-07T18:21:23.271Z monthly 0.7 https://buyandbillbrief.com/posts/payer-contract-reimbursement-rate-benchmarks-for-infusion-centers https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/bd632ea0-d72b-494f-b07a-772a937809c5/canvas/04650c8f-3633-4a80-aef4-41aa3d3b8a39/generated/c308ed1b-91de-472d-a17e-18ec2b6c3465.png 2026-10-06T18:40:09.729Z monthly 0.7 https://buyandbillbrief.com/posts/why-automation-only-rcm-fails-infusion-platforms-at-scale https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/bd632ea0-d72b-494f-b07a-772a937809c5/canvas/04650c8f-3633-4a80-aef4-41aa3d3b8a39/generated/884d980b-7846-4791-9bee-3b5a5d39f773.png 2026-10-05T20:15:37.563Z monthly 0.7 https://buyandbillbrief.com/posts/infusion-group-acquisition-valuation-and-revenue-cycle-quality https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/bd632ea0-d72b-494f-b07a-772a937809c5/canvas/04650c8f-3633-4a80-aef4-41aa3d3b8a39/generated/05e1471a-905c-4aad-b2ea-afa6759fd0d0.png 2026-10-04T20:04:52.445Z monthly 0.7 https://buyandbillbrief.com/posts/infusion-practice-ebitda-margin-benchmarks-by-operating-model https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/bd632ea0-d72b-494f-b07a-772a937809c5/canvas/04650c8f-3633-4a80-aef4-41aa3d3b8a39/generated/7a2409f5-edd1-496e-aa8b-3c52499fc4d2.png 2026-10-03T19:34:47.678Z monthly 0.7 https://buyandbillbrief.com/posts/due-diligence-on-infusion-rcm-operations-in-pe-acquisitions https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/bd632ea0-d72b-494f-b07a-772a937809c5/canvas/04650c8f-3633-4a80-aef4-41aa3d3b8a39/generated/123d255b-b09a-4cf9-82e7-5d2abe839ce0.png 2026-10-02T20:20:50.143Z monthly 0.7 https://buyandbillbrief.com/posts/rcm-performance-metrics-for-multi-site-infusion-platforms https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/bd632ea0-d72b-494f-b07a-772a937809c5/canvas/04650c8f-3633-4a80-aef4-41aa3d3b8a39/generated/b3bb0a11-cd84-4668-a0d7-46c32f50daa9.png 2026-10-01T20:25:06.810Z monthly 0.7 https://buyandbillbrief.com/posts/spread-economics-for-high-volume-infusion-biologics https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/bd632ea0-d72b-494f-b07a-772a937809c5/canvas/04650c8f-3633-4a80-aef4-41aa3d3b8a39/generated/f62a752d-7ae7-4565-8ac2-872d20a8fbe1.png 2026-09-30T18:20:24.851Z monthly 0.7 https://buyandbillbrief.com/posts/cms-quarterly-asp-updates-and-margin-volatility https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/bd632ea0-d72b-494f-b07a-772a937809c5/canvas/04650c8f-3633-4a80-aef4-41aa3d3b8a39/generated/e64671b7-cd29-4042-9c22-ee296c335fc0.png 2026-09-30T17:25:58.717Z monthly 0.7 https://buyandbillbrief.com/posts/wac-based-payer-contracts-and-spread-erosion-risk https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/bd632ea0-d72b-494f-b07a-772a937809c5/canvas/04650c8f-3633-4a80-aef4-41aa3d3b8a39/generated/238ef149-a1cd-4932-8417-8b806313ce3e.png 2026-09-29T08:20:55.213Z monthly 0.7 https://buyandbillbrief.com/posts/asp-plus-methodology-for-infusion-biologic-reimbursement https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/bd632ea0-d72b-494f-b07a-772a937809c5/canvas/04650c8f-3633-4a80-aef4-41aa3d3b8a39/generated/b79a593f-ff73-466d-922c-cea3470c77db.png 2026-09-27T02:30:11.643Z monthly 0.7 https://buyandbillbrief.com/posts/revenue-per-infusion-benchmarks-for-independent-infusion-groups https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/bd632ea0-d72b-494f-b07a-772a937809c5/canvas/04650c8f-3633-4a80-aef4-41aa3d3b8a39/generated/9a2ce15b-e74f-44e4-8f45-32c063b9f11f.png 2026-09-26T05:50:14.554Z monthly 0.7 https://buyandbillbrief.com/posts/biosimilar-substitution-financial-risk-in-buy-and-bill https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/bd632ea0-d72b-494f-b07a-772a937809c5/canvas/04650c8f-3633-4a80-aef4-41aa3d3b8a39/generated/bc773cab-4bca-4a62-a4a0-cf2e66167ab3.png 2026-09-23T23:18:07.162Z monthly 0.7 https://buyandbillbrief.com/posts/drug-waste-billing-compliance-in-infusion-reimbursement https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/bd632ea0-d72b-494f-b07a-772a937809c5/canvas/04650c8f-3633-4a80-aef4-41aa3d3b8a39/generated/9b27d9dc-f902-45c6-8ea1-20c7c2c0fe9d.png 2026-09-22T20:25:44.138Z monthly 0.7 https://buyandbillbrief.com/posts/prior-authorization-failure-as-a-drug-cost-liability-event https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/bd632ea0-d72b-494f-b07a-772a937809c5/canvas/04650c8f-3633-4a80-aef4-41aa3d3b8a39/generated/a6056a55-c9c3-4aa7-a2ce-0f6f549925ca.png 2026-09-21T20:19:58.265Z monthly 0.7 https://buyandbillbrief.com/posts/catastrophic-claim-concentration-risk-in-small-infusion-groups https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/bd632ea0-d72b-494f-b07a-772a937809c5/canvas/04650c8f-3633-4a80-aef4-41aa3d3b8a39/generated/c16616b7-4f74-4b87-a4c1-b69ad893b338.png 2026-09-20T20:19:10.806Z monthly 0.7 https://buyandbillbrief.com/posts/underpayment-vs-denial-risk-in-biologic-claims https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/bd632ea0-d72b-494f-b07a-772a937809c5/canvas/04650c8f-3633-4a80-aef4-41aa3d3b8a39/generated/2305e177-f75c-48be-bab7-b2d57f6d5b99.png 2026-09-19T18:29:37.462Z monthly 0.7 https://buyandbillbrief.com/posts/j-code-billing-errors-that-trigger-biologic-denials https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/bd632ea0-d72b-494f-b07a-772a937809c5/canvas/04650c8f-3633-4a80-aef4-41aa3d3b8a39/generated/011ac3dc-a21c-496b-9dc9-b27df1b13d3f.png 2026-09-18T19:50:16.566Z monthly 0.7 https://buyandbillbrief.com/posts/biologic-denial-financial-exposure-modeling https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/bd632ea0-d72b-494f-b07a-772a937809c5/canvas/04650c8f-3633-4a80-aef4-41aa3d3b8a39/generated/f9f840ec-9112-49cd-9015-9e77f93dda5b.png 2026-09-17T20:14:26.141Z monthly 0.7 https://buyandbillbrief.com/posts/centralized-vs-site-level-rcm-functions-in-an-infusion-mso https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/bd632ea0-d72b-494f-b07a-772a937809c5/canvas/04650c8f-3633-4a80-aef4-41aa3d3b8a39/generated/088c7e9c-8e38-4aa6-aa7f-9bf80b666b3a.png 2026-09-16T19:59:49.905Z monthly 0.7